Загрузка...
Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy
BACKGROUND: The development of ghost cell glaucoma in patients with proliferative diabetic retinopathy (PDR) after intravitreous injection (IV) was rare. Here we reported a series of patients with PDR who received Intravitreous Ranibizumab (IVR) and developed ghost cell glaucoma and analyzed the pot...
Сохранить в:
| Опубликовано в: : | BMC Ophthalmol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7161240/ https://ncbi.nlm.nih.gov/pubmed/32295566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-020-01422-z |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|